![Ron Chiarello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Ron Chiarello was the founder of Alveo Technologies, Inc., which was founded in 2014, where he held the title of Chairman & Chief Executive Officer.
Currently, he is the Chief Executive Officer at 54Gene, Inc. where he started in 2023 and is still active.
Posizioni attive di Ron Chiarello
Società | Posizione | Inizio |
---|---|---|
54Gene, Inc.
![]() 54Gene, Inc. BiotechnologyHealth Technology 54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023. | Amministratore Delegato | 15/03/2023 |
Precedenti posizioni note di Ron Chiarello
Società | Posizione | Fine |
---|---|---|
Alveo Technologies, Inc.
![]() Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Amministratore Delegato | 17/11/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Alveo Technologies, Inc.
![]() Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Health Technology |
54Gene, Inc.
![]() 54Gene, Inc. BiotechnologyHealth Technology 54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023. | Health Technology |
- Borsa valori
- Insiders
- Ron Chiarello